首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD217 Recombinant Antibody

Anti-Human CD217 Recombinant Antibody

产品编号

YR1255

别名

科研级 Brodalumab ( 布罗达单抗 ), Anti-CD217 Recombinant Antibody, Research Grade Brodalumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Brodalumab ( 布罗达单抗 ), Anti-CD217 Recombinant Antibody, Research Grade Brodalumab
Catalog NumberYR1255
Molecular NameBrodalumab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG2 Kappa
FormulationPBS, pH7.5
BackgroundBrodalumab (trade name Siliq in the US and Kyntheum in Europe) is a human monoclonal antibody designed for the treatment of inflammatory diseases. In February 2017 it received US FDA approval to treat moderate to severe plaque psoriasis in people who have not improved with other treatments. Use is linked to an increased risk of suicide.
CAS Number1174395-19-7
ApplicationWB, IF, IP, Neut, FuncS, ELISA, FCM
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD217[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价